Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion type Assertion NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_head.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion description "[The frequency of allelic loss in informative cases of metastatic mature teratoma was 27% (8 of 30) with D1S1646, 34% (10 of 29) with D9S171, 37% (10 of 27) with IFNA, 27% (8 of 30) with D9S303, 46% (13 of 28) with D13S317, 26% (7 of 27) with D18S543, and 36% (10 of 28) with D18S60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_provenance.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion evidence source_evidence_literature NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_provenance.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion SIO_000772 16982812 NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_provenance.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion wasDerivedFrom befree-20150227 NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_provenance.
- NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_assertion wasGeneratedBy ECO_0000203 NP478354.RAZkTt9Wp1rEk5FX90HIcLdlRc9oYwUL8TCMFe-JRhJvk130_provenance.